225 related articles for article (PubMed ID: 7654733)
1. Paramyxovirus infection in lung transplant recipients.
Wendt CH; Fox JM; Hertz MI
J Heart Lung Transplant; 1995; 14(3):479-85. PubMed ID: 7654733
[TBL] [Abstract][Full Text] [Related]
2. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.
Gottlieb J; Schulz TF; Welte T; Fuehner T; Dierich M; Simon AR; Engelmann I
Transplantation; 2009 May; 87(10):1530-7. PubMed ID: 19461490
[TBL] [Abstract][Full Text] [Related]
5. Parainfluenza virus respiratory infection after bone marrow transplantation.
Wendt CH; Weisdorf DJ; Jordan MC; Balfour HH; Hertz MI
N Engl J Med; 1992 Apr; 326(14):921-6. PubMed ID: 1311800
[TBL] [Abstract][Full Text] [Related]
6. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections.
Fuehner T; Dierich M; Duesberg C; DeWall C; Welte T; Haverich A; Warnecke G; Simon AR; Gottlieb J
Antivir Ther; 2011; 16(5):733-40. PubMed ID: 21817195
[TBL] [Abstract][Full Text] [Related]
7. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
9. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
[TBL] [Abstract][Full Text] [Related]
10. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
13. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.
Elizaga J; Olavarria E; Apperley J; Goldman J; Ward K
Clin Infect Dis; 2001 Feb; 32(3):413-8. PubMed ID: 11170949
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of parainfluenza virus infection in lung transplant recipients.
Vilchez RA; McCurry K; Dauber J; Iacono A; Keenan R; Zeevi A; Griffith B; Kusne S
Clin Infect Dis; 2001 Dec; 33(12):2004-8. PubMed ID: 11702289
[TBL] [Abstract][Full Text] [Related]
15. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus pneumonia in a lung transplant recipient: case report.
Doud JR; Hinkamp T; Garrity ER
J Heart Lung Transplant; 1992; 11(1 Pt 1):77-9. PubMed ID: 1540615
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
McCurdy LH; Milstone A; Dummer S
J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
19. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
[TBL] [Abstract][Full Text] [Related]
20. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
